McKesson Corporation
$837.14
▼
-0.61%
2026-04-22 10:12:13
www.mckesson.com
NYQ: MCK
Explore McKesson Corporation stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$102.52 B
Current Price
$837.14
52W High / Low
$999 / $637
Stock P/E
24.1
Book Value
$-10.55
Dividend Yield
0.38%
ROCE
35.58%
ROE
-162.92%
Face Value
—
EPS
$34.76
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Distribution
Employees
43,000
Beta
0.42
Debt / Equity
-3.56
Current Ratio
0.88
Quick Ratio
0.53
Forward P/E
19.61
Price / Sales
0.27
Enterprise Value
$113 B
EV / EBITDA
19.06
EV / Revenue
0.28
Rating
Buy
Target Price
$991.67
EPS Forecast (FY)
—
Pros
- Efficient use of capital employed.
- Balance sheet leverage appears manageable.
- Meaningful dividend yield is available.
Cons
- Return on equity is on the weaker side.
- Current ratio suggests tighter short-term liquidity.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Empro Group Inc. | $17.36 | — | $144.63 M | — | 39.59% | 66.26% | $18.14 / $2.55 | $1.02 |
| 2. | Henry Schein, Inc. | $78.73 | 24.1 | $9.06 B | — | 9.49% | 8.7% | $89.29 / $61.95 | $28.03 |
| 3. | Accendra Health, Inc. | $3.52 | — | $270.97 M | — | 14.74% | -1.64% | $9.55 / $1.84 | $-6.04 |
| 4. | Cardinal Health, Inc. | $202.95 | 29.15 | $47.74 B | 0.95% | 16.32% | -52.09% | $233.6 / $129.52 | $-12.22 |
| 5. | Synergy CHC Corp. | $0.51 | — | $5.93 M | — | -93.25% | 62.08% | $4 / $0.42 | $-0.73 |
| 6. | Cosmos Health Inc. | $0.38 | — | $20.65 M | — | -53.42% | -63.82% | $1.32 / $0.28 | $0.73 |
| 7. | Cencora, Inc. | $310.27 | — | $13.74 B | 0.73% | 20.96% | 1.33% | $377.54 / $271 | $9.81 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 106.16 B | 103.15 B | 97.83 B | 90.82 B | 95.29 B | — |
| Operating Profit | 1.66 B | 1.47 B | 1.08 B | 1.66 B | 1.26 B | — |
| Net Profit | 1.19 B | 1.11 B | 784 M | 1.26 B | 879 M | — |
| EPS in Rs | 9.68 | 9.06 | 6.4 | 10.29 | 7.18 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 359.05 B | 308.95 B | 276.71 B | 263.97 B |
| Operating Profit | 4.82 B | 4.17 B | 4.58 B | 2.59 B |
| Net Profit | 3.29 B | 3 B | 3.56 B | 1.11 B |
| EPS in Rs | 26.9 | 24.51 | 29.06 | 9.09 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 75.14 B | 67.44 B | 62.32 B | 63.3 B |
| Total Liabilities | 76.83 B | 69.04 B | 63.81 B | 65.09 B |
| Equity | -2.07 B | -1.97 B | -1.86 B | -2.27 B |
| Current Assets | 55.4 B | 47.97 B | 44.29 B | 46.23 B |
| Current Liabilities | 61.6 B | 52.36 B | 47.96 B | 48.47 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 6.08 B | 4.31 B | 5.16 B | 4.43 B |
| Investing CF | -733 M | -1.07 B | -542 M | -89 M |
| Financing CF | -3.96 B | -3.34 B | -4.37 B | -6.32 B |
| Free CF | 5.23 B | 3.63 B | 4.6 B | 3.9 B |
| Capex | -859 M | -687 M | -558 M | -535 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | 16.22% | 11.65% | 4.83% | — |
| Earnings Growth % | 9.76% | -15.67% | 219.57% | — |
| Profit Margin % | 0.92% | 0.97% | 1.29% | 0.42% |
| Operating Margin % | 1.34% | 1.35% | 1.66% | 0.98% |
| Gross Margin % | 3.71% | 4.15% | 4.47% | 4.97% |
| EBITDA Margin % | 1.46% | 1.51% | 1.98% | 1.09% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2026-03-02 | $0.82 |
| 2025-12-01 | $0.82 |
| 2025-09-02 | $0.82 |
| 2025-06-02 | $0.71 |
| 2025-03-03 | $0.71 |
Stock Splits
No stock split history available.